Dr Thomas Edward Munshower, DO | |
Route 209, Harleysville National Bank Building, Kresgeville, PA 18333 | |
(610) 681-6800 | |
(610) 681-6825 |
Full Name | Dr Thomas Edward Munshower |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 35 Years |
Location | Route 209, Kresgeville, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669436432 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OS-007201-L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Southeastern Home Health Services | Bristol, PA | Home health agency |
Bayada Home Health Care, Inc. | Bethlehem, PA | Home health agency |
St Luke's Hospital - Monroe Campus | Stroudsburg, PA | Hospital |
St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
St Luke's Miners Memorial Hospital | Coaldale, PA | Hospital |
Lehigh Valley Hospital - Pocono | East stroudsburg, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Luke's Physician Group Inc | 6709798333 | 1739 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone Gel, 1%. Watson's 1% testosterone gel product is a generic version of Auxilium Pharmaceuticals, Inc.'s Testim 1%.
A blood test that can detect tiny amounts of circulating cancer DNA may be able to identify risk of cancer recurrence and guide precision treatment in bladder cancer following surgery, according to a clinical study led byProfessor Tom Powles from Queen Mary University of London andBarts Health NHS Trust.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry recently completed another successful showcase of its Unified eClinical Solution at the annual DIA show. DATATRAK's premier Solution coupled with the DATATRAK ONE business model are hallmarks of its singular technological vision and unwavering commitment to customers.
Women fighting breast cancer after a lumpectomy have a new weapon in the battle, now available at Jupiter Medical Center's Foshay Cancer Center. Today, the hospital began treating patients with the Multi-Lumen MammoSite(R) device, just approved in September by the FDA.
› Verified 6 days ago
Entity Name | St Lukes Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone Gel, 1%. Watson's 1% testosterone gel product is a generic version of Auxilium Pharmaceuticals, Inc.'s Testim 1%.
A blood test that can detect tiny amounts of circulating cancer DNA may be able to identify risk of cancer recurrence and guide precision treatment in bladder cancer following surgery, according to a clinical study led byProfessor Tom Powles from Queen Mary University of London andBarts Health NHS Trust.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry recently completed another successful showcase of its Unified eClinical Solution at the annual DIA show. DATATRAK's premier Solution coupled with the DATATRAK ONE business model are hallmarks of its singular technological vision and unwavering commitment to customers.
Women fighting breast cancer after a lumpectomy have a new weapon in the battle, now available at Jupiter Medical Center's Foshay Cancer Center. Today, the hospital began treating patients with the Multi-Lumen MammoSite(R) device, just approved in September by the FDA.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Thomas Edward Munshower, DO Po Box 550 Route 209, Harleysville National Bank, Kresgeville, PA 18333-0550 Ph: (610) 681-6800 | Dr Thomas Edward Munshower, DO Route 209, Harleysville National Bank Building, Kresgeville, PA 18333 Ph: (610) 681-6800 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone Gel, 1%. Watson's 1% testosterone gel product is a generic version of Auxilium Pharmaceuticals, Inc.'s Testim 1%.
A blood test that can detect tiny amounts of circulating cancer DNA may be able to identify risk of cancer recurrence and guide precision treatment in bladder cancer following surgery, according to a clinical study led byProfessor Tom Powles from Queen Mary University of London andBarts Health NHS Trust.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry recently completed another successful showcase of its Unified eClinical Solution at the annual DIA show. DATATRAK's premier Solution coupled with the DATATRAK ONE business model are hallmarks of its singular technological vision and unwavering commitment to customers.
Women fighting breast cancer after a lumpectomy have a new weapon in the battle, now available at Jupiter Medical Center's Foshay Cancer Center. Today, the hospital began treating patients with the Multi-Lumen MammoSite(R) device, just approved in September by the FDA.
› Verified 6 days ago